We are at a watershed moment in healthcare. The entire industry is being compelled to question old assumptions and chart a new path forward - in a word, we need to pivot. This podcast hosted by the editorial team at MedCity News will highlight the strategies, the companies and the personalities spearheading this monumental transformation.
Executive Summary Insurance companies are moving fast on agentic AI, and Aetna is one of the clearest examples of what that looks like in production. In this episode, Nathan Frank, Chief Digital and Technology Officer at Aetna, the insurance business of CVS Health, explains how AI agents are cutting administrative burden for nurses, why Aetna refuses to use AI for care denials, and what it will take to give every member their own AI health agent within the year.
Key Takeaways * Aetna's AI agents pull data from multiple platforms, providers, and EHRs to prepare clinical notes automatically, giving the company's 12,000 care management nurses 90 minutes back per day. * Aetna does not use AI to deny care. Nathan Frank draws a hard line here: AI supports auto-approvals and administrative work, but clinicians review any case with missing information. * 84% of providers in Aetna's annual survey believe AI and agentic AI will lead to better outcomes, a signal the company is using to justify deeper investment in interoperability and clinical data exchange. * An early version of an AI scheduling agent is already in production, handling the "homework" of booking appointments. Nathan expects a fully autonomous AI health agent for members within the next year. * Model cost management is becoming a core discipline: Aetna is routing workflows to lower-cost models where possible instead of defaulting every task to frontier AI.
Links and Resources * Connect with Arundhati Parmar * aparmar@medcitynews.com * Arundhati Parmar (@aparmarbb) on X — https://twitter.com/aparmarbb?lang=en * MedCity News — https://medcitynews.com/
Keywords agentic AI healthcare, Aetna AI, Nathan Frank Aetna, CVS Health AI, AI in health insurance, ambient listening healthcare, AI care management, administrative burden AI, health insurance AI trust, AI claims processing, AI appointment scheduling, health plan AI agents, payer AI strategy, CVS Health Ventures, AI model cost management, interoperability healthcare AI, AI care denials, MedCity Pivot podcast, healthcare AI startups, member experience AI
Episode Highlights * [00:03:00 - 00:04:00] How Aetna's AI agents pull data from multiple EHRs to prepare clinical notes for nurses before patient visits * [00:04:00 - 00:04:30] The result: 90 minutes back per day for clinicians, redirected to patient care, not homework * [00:06:00 - 00:07:00] Aetna's 10-plus years of AI and machine learning history, and its 3,000 data scientists * [00:12:00 - 00:12:30] Nathan Frank's direct statement: Aetna does not use AI to deny care * [00:13:00 - 00:13:30] The provider survey finding that 84% believe agentic AI will lead to better outcomes * [00:16:00 - 00:17:00] How Aetna sorts signal from noise among healthcare AI startups * [00:21:00 - 00:22:00] An early version of the AI scheduling agent is already live, with a fully autonomous member health agent expected within the year
SUMMARY
Arundhati Parmar speaks with Jill Schwartz-Chevlin, Chief Medical Officer at Vinca, about the evolution of palliative care from a hospital-based, end-of-life service to a community and home-based model for patients living with serious illness. Jill explains how Vinca grew from an advanced care planning platform into a value-based palliative care company serving patients across five states, primarily through Medicaid and Medicare Advantage plans.
The conversation covers the critical distinction between palliative care and hospice, the cost savings data that health plans are paying attention to, and what it will take for Medicare to finally build a sustainable reimbursement model for the specialty.
KEY TAKEAWAYS
KEYWORDS
palliative care at home, home-based palliative care, serious illness management, palliative care vs hospice, Vinca health, value-based palliative care, Medicaid palliative care benefit, Medicare Advantage palliative care, community palliative care, advanced care planning, hospice length of stay, ER reduction palliative care, whole-person care, serious illness, home health palliative care, CMO interview healthcare, palliative care reimbursement, MedCity Pivot podcast
Links and resources
EPISODE HIGHLIGHTS
Episode Summary Particle Health CEO Jason Prestinario joins MedCity Pivot to assess the state of U.S. healthcare interoperability with clear-eyed candor. He grades the technical infrastructure a B — data can move — but gives access governance a C, because the rules around who uses data, and how, remain murky and poorly enforced. Jason draws a direct line between true interoperability and the viability of value-based care: without frictionless data access, accountability for patient outcomes is impossible.
The conversation also covers Particle's antitrust lawsuit against Epic, now past its first major legal hurdle, and the broader wave of litigation challenging Epic's market dominance. Jason urges nuance: there's a meaningful difference between patients authorizing their own data use and bad actors harvesting records without consent — and conflating the two risks setting back the entire data-sharing ecosystem.
Key Takeaways * The data infrastructure gets a B — but access governance is still a C. The technical pipes for moving health records exist, but who can use them, when, and for what purpose remains the critical unsolved problem. * Interoperability is a 'nice to have' in fee-for-service care — but it's a hard requirement for value-based care. When a provider is accountable for outcomes that happen outside their four walls, they need data from outside those walls. * Information blocking penalties need teeth. Until healthcare organizations believe violations will result in real consequences, the rules won't change behavior — just like speed limits only work when drivers believe tickets are real. * There's a critical distinction between patients authorizing their own data use and third parties accessing data without consent. The current Epic lawsuit debate conflates two very different scenarios that deserve separate legal and regulatory treatment. * True patient data ownership is still largely a myth. Despite portals and progress, patients still face significant barriers — forgotten logins, provider-controlled systems — to accessing their own medical records programmatically.
Links and Resources * Connect with Arundhati Parmar * aparmar@medcitynews.com * Arundhati Parmar (@aparmarbb) on X * MedCity News
Keywords healthcare interoperability, Particle Health, Jason Prestinario, Epic lawsuit, antitrust healthcare, value-based care, CMS interoperability, TEFCA, Carequality, health data access, information blocking, 21st Century Cures Act, patient data ownership, HIPAA compliance, health information exchange, payer interoperability, digital health data, EHR data sharing, CommonWell, ONC rules
Episode Highlights * [00:04:22 - 00:05:16] Jason grades the interoperability 'pipes' a B-plus but gives data access governance a C at best. * [00:10:56 - 00:12:37] Interoperability shifts from 'nice to have' in fee-for-service to a hard requirement in value-based care. * [00:17:05 - 00:19:27] Jason explains why Particle sued Epic and what the case means for the broader healthcare data ecosystem. * [00:25:11 - 00:27:11] A key distinction: patient-authorized data use versus unauthorized third-party data harvesting. * [00:28:34 - 00:32:44] Why patients still can't easily access their own records — and what it would take to change that. * [00:29:02 - 00:29:41] Information blocking penalties only work when organizations believe the consequences are real.
Episode Summary In this episode of the MedCity Pivot Podcast, host Arundhati Parmar sits down with Javier Gonzalez (Abarca Health) and Tanvi Patel (Amazon Pharmacy) to unpack one of healthcare's most frustrating processes: prior authorization.
The conversation explores how outdated systems, lack of transparency, and fragmented communication are eroding patient trust and delaying care. From policy complexity and data gaps to operational risks, the guests break down why prior authorization remains such a challenge—and what it will take to modernize it at scale.
They also highlight the critical role of transparency, interoperability, and consumer expectations in shaping the future of healthcare. With insights from both payer and pharmacy perspectives, this episode paints a clear vision of a more patient-centered system where access to medication is faster, clearer, and more trustworthy
Links & Resources * Connect with Arundhati Parmar * aparmar@medcitynews.com * https://twitter.com/aparmarbb?lang=en * https://medcitynews.com/
Keywords prior authorization healthcare transparency patient trust interoperability digital pharmacy healthcare innovation medication adherence health tech ePA patient experience healthcare systems PBM reform Amazon Pharmacy Abarca Health
Episode Highlights * 00:00–00:25 – Introduction to prior authorization challenges and patient frustration * 00:01–00:49 – Overview of modernization efforts in healthcare systems * 00:01:27–00:03:31 – The three core challenges: policy complexity, data quality, operational risk * 00:04:11–00:04:29 – Real-life impact: delays in critical care (cancer case) * 00:04:36–00:05:22 – How prior authorization erodes patient trust * 00:05:59–00:07:00 – Medication adherence begins before the first dose * 00:07:00–00:07:18 – 20–30% drop-off due to prior authorization failures * 00:07:18–00:07:39 – Transparency as the key to patient engagement * 00:08:20–00:09:45 – Benefits of electronic workflows (60–70% efficiency gains) * 00:11:18–00:12:24 – What should be eliminated in a redesigned system * 00:12:47–00:13:55 – Employers' role in improving benefit transparency * 00:15:23–00:16:21 – Rise of modular PBM models and industry shifts * 00:20:46–00:22:11 – Misaligned incentives across healthcare stakeholders * 00:23:51–00:24:45 – Consumer expectations reshaping healthcare timelines * 00:25:14–00:26:11 – The future: invisible, frictionless prior authorization
Summary In this episode of the Med City Pivot Podcast, host Arundhati Parmar speaks with Lars Petersen about one of the most remarkable corporate transformations in modern business history.
Facing a catastrophic collapse of its core film business in the mid-2000s due to the rise of digital photography, Fujifilm executed a bold and strategic pivot into healthcare and life sciences. The company diversified aggressively, leveraging its deep expertise in materials science, imaging, and innovation to build a thriving biotechnology and medical technology ecosystem.
Today, Fujifilm operates as a global Contract Development and Manufacturing Organization (CDMO), partnering with leading pharmaceutical companies and startups alike. The conversation explores how strategic investment, diversification, long-term thinking, and innovation—including AI—enabled Fujifilm not just to survive, but to lead in a completely new industry.
Links & Resources * Connect with Arundhati Parmar * aparmar@medcitynews.com * https://twitter.com/aparmarbb?lang=en * https://medcitynews.com/
Keywords Fujifilm Pivot Healthcare CDMO Biotechnology Biologics digital transformation business strategy Innovation AI in healthcare Pharma Manufacturing monoclonal antibodies gene therapy cell therapy Diversification corporate strategy MedTech
Episode Highlights * 00:00–00:23 – Introduction to the concept of "pivot" and Fujifilm's survival story * 00:00–00:47 – The collapse of the film industry and existential crisis * 00:00–01:15 – Fujifilm's transformation into a healthcare company * 00:02:39–00:03:28 – 2006: the pivotal year and 60% revenue loss * 00:03:28–00:03:45 – Strategic decision to diversify long-term * 00:04:22–00:05:08 – Why Fujifilm succeeded while competitors failed * 00:05:35–00:06:26 – Key investments and acquisitions (including Biogen assets) * 00:06:52–00:07:30 – Why healthcare is a stable, long-term growth industry * 00:07:53–00:08:29 – Expansion into medical devices and imaging technologies * 00:09:42–00:10:34 – Core therapeutic focus: biologics, gene therapy, cell therapy * 00:10:49–00:11:22 – Serving both startups and global pharma giants * 00:12:39–00:13:40 – Competitive positioning vs. Samsung Biologics & Lonza * 00:15:08–00:15:44 – "Partners for life" philosophy and long-term trust * 00:17:52–00:18:49 – AI integration across manufacturing ecosystems * 00:18:54–00:19:42 – Final takeaway: building shared ecosystems for the future of medicine
EPISODE SUMMARY In this episode, Arundhati Parmar interviews Shalin Shah, CEO of Marius Pharmaceuticals, about Testosterone Replacement Therapy (TRT) and the long-standing regulatory classification that places testosterone as a Schedule III controlled substance.
Shah explains that testosterone was scheduled in 1990 following Olympic doping scandals — despite opposition at the time from the FDA, DEA, and the American Medical Association. More than 30 years later, he argues that the regulatory framework no longer reflects current clinical evidence and may be doing more harm than good.
The conversation explores:
At its core, this episode examines whether testosterone is being regulated based on outdated controversy rather than modern clinical science — and what that means for patients navigating care today.
Episode Resources * Connect with Arundhati Parmar * aparmar@medcitynews.com * https://twitter.com/aparmarbb?lang=en * https://medcitynews.com/
KEYWORDS Testosterone Replacement Therapy TRT regulation Schedule III classification Controlled substances Hormone therapy stigma Men's health Women's hormone therapy TRAVERSE study Cardiovascular risk Prostate cancer risk Oral testosterone Injectable testosterone Hematocrit levels GLP-1 muscle loss Hypogonadism FDA regulation Healthcare policy Hormone optimization
EPISODE HIGHLIGHTS 00:00–01:40 - Why testosterone became a Schedule III controlled substance in 1990 01:40–02:30 - Political backlash after Olympic doping scandals 02:30–03:56 - Testosterone as the only controlled hormone 03:56–04:58 - The physiologic role of testosterone across multiple organ systems 04:58–06:19 - Cardiovascular and prostate cancer risk: What the TRAVERSE study showed 06:19–07:04 - Physiologic vs. supraphysiologic dosing 07:04–08:49 - How controlled status creates stigma and access barriers 08:49–10:10 - Provider tracking, pharmacy hurdles, and patient friction 10:10–11:48 - Would deregulation increase abuse or doping? 11:48–13:20 - GLP-1 drugs, rapid weight loss, and muscle preservation 13:20–15:08 - Testosterone in women: The overlooked half of the population 15:08–16:22 - Injectable vs oral TRT: Mimicking natural diurnal rhythms 16:22–17:40 - Hematocrit elevation differences between injections and oral therapy 17:40–19:07 - Side effect profiles and hormone signaling differences 19:07–20:32 - Go-to-market strategy: Cash pay vs insurance coverage 20:32–21:24 - Stigma among payers and barriers to reimbursement 21:24–22:43 - Expanding label indications and idiopathic hypogonadism 22:43–22:22 - Could the current administration reconsider testosterone scheduling?
Summary
Tune into MedCity Pivot Podcast with host Arundhati Parmar as three healthcare tech leaders—Serge Perras, Ton Roelandse, and Bertil Chappuis—decode AI's true potential in healthcare. Explore its role in enhancing efficiency and busting myths about AI supremacy.
Episode Highlights
00:00:19 - The high bar for AI safety in healthcare.
00:01:29 - AI's current hype and exaggerated promises.
00:03:57 - Misconceptions about AI replacing healthcare roles.
00:05:51 - Meaningful AI use cases: Prior authorization automation.
00:06:52 - AI in triage and its capacity enhancements.
00:08:10 - AI's role in modernizing healthcare infrastructure.
00:10:46 - Clarifying AI vs. RPA in tech solutions.
00:13:30 - Importance of governance and guardrails in AI.
00:16:38 - Humanizing healthcare through AI.
00:18:27 - AI's potential and challenges in medical coding.
00:21:31 - AI's impact on job roles and productivity boosts.
00:24:25 - Use of AI in personal life for everyday tasks.
Episode Resources
Keywords
During the episode, MedCity News Associate Editor Katie Adams interviews Dr. Hamad Husainy, chief medical officer at PointClickCare, and Dr. Barbara Bond, a physician at Sutter Health, about how AI can help improve patient outcomes in the emergency department.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you're subscribed to the podcast so you get the latest episodes.
I interviewed Adriana Ramirez and Matt Gibbs, and we spoke about how a new approach to pharmacy benefits management.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you're subscribed to the podcast so you get the latest episodes.
I am interviewing Dr. Iftach Dolev, co-founder and CEO of QuantalX a neurodiagnostics company that has just received FDA clearance for its device.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you're subscribed to the podcast so you get the latest episodes.
This episode was sponsored by Quantum Health. Katie Adams, associate editor at MedCity News, interviewed Shannon Skaggs, chief AI officer at Quantum Health, about how AI is reshaping the care navigation and benefits guidance world.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you're subscribed to the podcast so you get the latest episodes.
I interviewed Dr. Rowland Illing, Chief Medical Officer of AWS (Amazon Web Services) about its Health Data Lake and how those data are being powered into innovations transforming healthcare.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you're subscribed to the podcast so you get the latest episodes.
I interviewed two healthcare executives and we talked about the importance of price transparency in pharmacy benefits management to make life easier for patients taking prescription medications and for providers who use e-prescribing.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Jeremy Delinsky, CEO of Smarter Technologies, about AI-driven clinical documentation improvement and RCM revenue cycle management.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
This is an episode sponsored by Zelis, in which Katie Adams (assistant editor, MedCity News) interviews Yusuf Qasim (president of payments optimization, Zelis). He speaks about how a better healthcare payment experience can lead to better payer-provider relationships, as well as how his company's tech platform assists both of these players.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Aimee Garza about her startup, CoraVie Medical. I also interviewed Dr. Michael Bloch, who is one of the startup's clinical partners.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Dr. Roxana Dronca and Dr. Jeremy Jones who are both oncologists and are leads of Mayo Clinic's Cancer Care Beyond Walls program. Dr. Dronca had the idea of trying to find a way to deliver care of cancer patients in their home and Dr. Jones is responsible for bringing this model to other sites and even partner hospitals.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed James Lu, CEO of Helix, about precision medicine and whether it has been successful in terms of practical applications that improve patients' lives.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
This is a sponsored podcast interview with Megan Zakrewsky, vice president of product at Veradigm. We talked about how the company is using tech to drive behavior change among providers, payers and patients.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed the CEO of Immuneering and talked with him about how traditional approaches toward treating certain cancers may be missing the mark in terms of not only survival but also quality of life.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I spoke with Bryan Marlatt, Chief Regional Officer at CyXcel, a business advisory focusing on cybersecurity.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed David Bardan, VP of Healthcare at Clear, who explained how the company can help health systems boost their cybersecurity standards.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
This episode focuses on healthcare cybersecurity and a new set of standards established by the IEEE (Institute of Electrical and Electronics Engineers). MedCity News Assistant Editor Katie Adams interviewed Florence Hudson, who serves as chair of the IEEE working group that created this new framework. The pair discussed the new framework, as well as talked about the state of healthcare cybersecurity and explored what resource-strapped organizations can do to comply with new cybersecurity protocols.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
Heather Cox, President of Insights & Empowerment at Zelis, talked about the company's care coordination tools with MedCity News Reporter Katie Adams. She also shared how the company works with health plans to communicate with members to help them make proactive healthcare decisions, such as getting a flu shot or what to do in acute care situations, such as when they've had a bicycle accident.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Dr. Shantanu Nundy, EVP and Chief Health Officer of Accolade about how Accolade can help self-insured employers manage and lower their healthcare costs.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Jeff Jacques, chief medical officer of Personify Health about how employers are looking at GLP-1s as part of their overall employee benefits package.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, and talked about the challenges that self-insured employers face in managing their healthcare coverage costs.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Dr. Timothy Showalter, chief medical officer of Artera, which has devised an AI tool that can read digital pathology slides to recommend appropriate treatment for patients with localized prostate cancer.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Nate Wilson, co-founder and COO of Regard, and Dr. Joe Evans, Chief Medical Information Officer of Sentara Health, about how Sentara Health is applying artificial intelligence in their facilities.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Vicky Demas, CEO of Identifeye Health, a medtech company that has developed a device and AI algorithm to image the eye and diagnose a variety of diseases.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Rick Ratliff, CEO of MedAdvisor Solutions about the challenges facing pharmacies and how they can provide more support to patients in the future.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Tracey James, chief operating officer, Walgreens Specialty Enterprise about how Walgreens is trying to improve affordability and accessibility of specialty drugs.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed AJ Loiacono, CEO of Capital Rx about how the world of pharmacy and Pharmacy benefit management has evolved.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Scott Davis, CEO of Ekso Bionics about his company's wearable exoskeletons meant for people with spinal cord injury.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Daniel Tal Mor and discussed how the Lumen device can help users gain a better understanding of their metabolism and help them to lose weight.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Anne Osdoit, CEO of Moon Surgical, about how the company's Maestro System can bring the benefits of surgical robotics to certain types of surgeries without breaking the bank.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Beth Wrobel, CEO of HealthLinc to understand how she used a digital screening tool to understand patients' needs and ultimately help them to be more engaged in their health.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Dr Brian Clear about how opioid addiction treatment can be made easily accessible for people of color and with lower incomes.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Dr. Jackson, system vice president of population health innovation and policy at CommonSpirit Health about health equity and the programs she is running at the Lloyd H. Dean Institute for Human-kindness and Health Justice.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Ruch Horgan who lost his younger brother to a rare disease last year and we talked about a different approach to developing new therapies for rare and ultra rare disease patients.
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I spoke with Charles Fisher about his company's Digital Twin technology.
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Dr. Sumanta Pal, co-director of the Kidney Cancer Program, City of Hope, about a study he led on the effects of continuing immunotherapy in metastatic kidney cancer patients after it has stopped working.
Episode Sponsored By
https://www.carta.healthcare/
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I spoke with two executives - Punit Soni, CEO of Suki and Niall O'Connor, CTO of Cohere Health- about how their companies are trying to tackle the problem of burnout and prior authorization and help providers.
Episode Sponsored By
https://www.carta.healthcare/
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I spoke with Suchi Saria, Director of the Machine Learning, AI and Healthcare Lab at Johns Hopkins and CEO of Bayesian Health, about trustworthy and responsible AI.
Episode Sponsored By https://www.carta.healthcare/
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Jeff Sherman, CEO of Zephyr AI about the company's vision in transforming precision medicine.
Episode Sponsored By https://www.carta.healthcare/
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Paul Markovich, CEO of Blue Shield of California about its Wellvolution platform and chronic disease management.
Episode Sponsored By Gilead
Episode Resources
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Steve Driver with Advocate Aurora Health and we talked about how clinicians are using digital tools to manage heart failure and people at risk of getting diabetes.
Episode Sponsored By
Review, Subscribe and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
I interviewed Stephanie Tilenius, CEO of Vida Health, about her vision of holistic patient care.
Episode Sponsored By Gilead
Episode Resources
Review, Subscribe, and Share If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
For today’s episode, I interviewed the CEO of Zocdoc, Oliver Kharraz, about the future of telehealth.
Episode Sponsored By Gilead
Episode Resources
For today’s episode, I interviewed Miruna Sasu about Real World Evidence and how that is changing the world of drug development and clinical trials.
Who’s The Guest?
Miruna Sasu, PhD, MBA is the President and CEO of COTA. She has more than 20 years of experience at leading life science organizations such as Johnson & Johnson and Bristol-Myers Squibb. She also has both a Ph.D. in biology and statistics and a master’s in business administration.
Miruna is an accomplished executive with a track record of success when it comes to driving broad-based digital innovation. She brings her deep experience in the utilization and scaling of emerging innovations to advance drug portfolios.
Episode Sponsored By
Gilead
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
For today’s episode, I interviewed Sonia Millsom to talk about the trends in the healthcare executive search market. We also discuss the progress that has been made in terms of the diversity in the leadership roles in healthcare organizations, and the tension that exists between the desire for experienced executives and the lack of women and people of color in those roles.
Who’s The Guest?
Sonia Millsom is a veteran healthcare leader. With expensive experience in growing mission-driven innovative healthcare companies, she is passionate about driving change in healthcare to improve people’s access to quality care.
Currently, Sonia is the Chief Executive Officer at Oxeon, a trusted healthcare firm powering change through talent, entrepreneurship, and investments.
Episode Sponsored By
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
For today’s episode, I interviewed Anu Osinusi, Vice President of Clinical Research for Hepatitis, Respiratory and Emerging Viruses at Gilead. She talks about how Gilead is at the forefront of battling viral diseases as well as the solutions they are formulating to ensure that each and every person has access to treatments for future pandemics and to preserve global health across the globe.
Who’s The Guest?
Anu Osinusi serves as the Vice President of Clinical Development at Gilead Sciences. As a clinician-researcher with more than 15 years of experience in drug development, liver diseases, infectious diseases, and global health, she is responsible for overseeing the Viral Hepatitis (Hep B, C, and D), Respiratory and Emerging (COVID-19, Ebola, RSV, and others) Viruses portfolio.
Episode Sponsored By
Gilead
Episode Resources
Review, Subscribe and Share
If you like what you hear please leave a review by clicking here
Make sure you’re subscribed to the podcast so you get the latest episodes.
Daniel Perez is the CEO of Hinge Health. Hinge Health is pioneering the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic. They reduce MSK pain, opioid use, and surgeries by pairing advanced wearable technology with a comprehensive clinical care team, including doctors of physical therapy, physicians, board-certified health coaches, and more.
Summary
I interviewed Dan Perez, CEO of Hinge Health about the value of digital health technologies and how they can lower healthcare costs.
Episode Resources
Daniel Perez is the CEO of Hinge Health. Hinge Health is pioneering the world’s most patient-centered Digital Musculoskeletal (MSK) Clinic. They reduce MSK pain, opioid use, and surgeries by pairing advanced wearable technology with a comprehensive clinical care team, including doctors of physical therapy, physicians, board-certified health coaches, and more.
Summary
I interviewed Dan Perez, CEO of Hinge Health about the value of digital health technologies and how they can lower healthcare costs.
Episode Resources
I interviewed Renee Ryan, CEO of Cala Health, and discussed how a new generation of wearables can address neurological disorders like essential tremors.
Episode Resources
I interviewed Kevin Dedner and spoke about how to achieve cultural humility when delivering care for BIPOC people.
Episode Resources
Co-Founder and CEO of Wheel, Michelle Davey joins us to discuss how her company is at the forefront of making virtual care more accessible for patients and clinicians.
Episode Resources
I interviewed Ido Schoenberg, CEO of Amwell. We talked about a new model of care delivery that leverages virtual care.
Episode Resources
I interviewed Mike Alkire, CEO of Premier, and discussed how important it is for health systems to achieve scale.
Episode Resources
I spoke with the Chief Medical Officer of Buoy Health, Adrienne McFadden, about how the company has evolved from a symptom checker to a decision support and navigation company.
Episode Resources
I interviewed Jonathan Bush, former CEO of Athenahealth and current CEO of Zus Health, about how to get a universal patient record.
Episode Resources
I interviewed John Martin, Chief Medical Officer of Butterfly Network, to talk about the company's evolution and goals of bringing universal access to point-of-care ultrasound.
Episode Resources
Arundhati welcomes Barry Ticho, Chief Medical Officer of Stoke Therapeutics. He discusses a new promising treatment of a rare disease called Dravet Syndrome. Episode Resources
Arundhati welcomes Taha Kass-Hout. Taha talks about his vision of leveraging AI to improve healthcare. He also discusses his experiences working for Amazon and how Amazon is helping improve our lives. Taha gives a deep insight on where artificial intelligence can go and what people should look forward to.
Episode Resources
Arundhati sits down with Larry Wood, the Corporate Vice President, TAVR with Edwards Lifesciences. Larry talks about how transcatheter valve replacement has revolutionized the treatment of aortic stenosis. He also shares what the future of aortic stenosis is and what people should look forward to in the next ten years.
Episode Resources
Arundhati welcomes Julia Hu, the CEO of Lark Health. They speak about conversational AI and how it can support chronic disease management and improve patient outcomes. Julia also shares the beliefs of Lark Health in solving the different health issues today. She also talks about the different programs of Lark Health and how they help clients.
Episode Resources
Arundhati interviews Carolyn With, the co-founder and CEO of the startup company, Tia. Together, they discuss the biggest pain points in women’s healthcare today and the health inquiries that exist in the space. Carolyn also shares how Tia is tackling these problems, as well as its recent achievements and their growth plans.
Episode Resources
Reporters at MedCity News discuss their coverage areas interests and share what pitches are interesting and what is not.
Episode Resources
Arundhati interviewed Sarah Boyce, CEO of Avidity Biosciences. In October 2019, Sarah Boyce joined Avidity as President and CEO, and she serves as a member of the board of directors. Ms. Boyce brings to Avidity extensive operational, commercial and leadership experience in the life sciences industry and has built global organizations, bringing a number of innovative therapies including Tegsedi®, Waylivra®, Soliris®, Gleevec® and Tasigna® to patients.
Episode Resources
Arundhati interviewed Dr. Robert Pearl who has written a book about how physician culture needs to be urgently reformed to benefit both patients and the healthcare industry.
Episode Resources
Arundhati interviewed Dr. Erich Huang, Chief Data Officer for Quality at Duke Health, and the Director of Duke Forge. They talk about why more hospitals are implementing machine learning tools for healthcare, and the challenges of ensuring these models do not yield biased results.
Episode Resources
Arundhati interviewed Glen Tullman to talk about his new venture and how he wants to transform the employee benefits and care navigation market.
Episode Resources
Arundhati interviewed Ho Cho, senior vice president of Discovery Biotherapeutics at BMS talking about drug discovery and the interesting therapies that BMS is developing to treat myeloma and lupus.
Episode Resources
Arundhati interviews Sean Slovenski, CEO of BioiQ, and they talk about how Covid-19 has affected the world of diagnostics and at-home testing.
Episode Resources
Arundhati interviewed Dr. Ami Bhatt, a cardiologist with Mass General Brigham, about the value of virtual care. Dr. Ami Bhatt specializes in lifelong care and empowerment of Teens and Adults with Congenital Heart Disease. He addresses valve problems, heart failure, multidisciplinary surgery, arrhythmia, pregnancy, transition, telemedicine & wellness programs.
Dr. Bhatt is an active clinical cardiologist, clinical investigator, and educator. She graduated from Harvard University, obtained her doctoral degree from Yale School of Medicine, and then trained at BWH. She works at the Children's Hospital of Boston and Mass General in internal medicine, pediatrics, cardiology, and adult congenital heart disease (ACHD).
Episode Resources
Arundhati interviewed Sree Chaguturu, chief medical officer of CVS Caremark and they discussed Covid-19 testing and vaccine distribution among other things.
Episode Resources
Arundhati interviewed Daniel Levner, co-founder of Sight Diagnostics, to talk about how machine learning can transform the field of complete blood count testing.
Episode Resources
Arundhati interviewed Mark Bertolini, the former CEO and Chairman of Aetna, about the future of health insurance.
Episode Resources
AstraZeneca US Head of Medical Affairs Oncology Camille Hertzka shares the pharma company's most recent lung cancer treatment study findings and insights on the changing landscape of lung cancer treatment driven by precision medicine.
Episode Resources
Arundhati interviewed Carolyn Magill, CEO of Aetion. They discussed the growing importance of real-world evidence in getting drugs approved and reimbursed.
Episode Resources
Arundhati interviewed Ezekiel Emanuel, who is on Joe Biden's Coronavirus task force. They discussed healthcare policy, what we can learn from other healthcare systems around the world, and how to manage COVID-19.
Episode Resources
Arundhati interviewed Bari Kowal, Vice President & Head at Global Clinical Operations, about COVID-19 and how the pharma industry needs to change.
Episode Resources
A conversation with Rita Khan, the First Chief Digital Officer of Mayo Clinic, about digital health during Covid-19.
Episode Resources
Andy Ellner is the founder of Firefly Health. Arundhati and Andy spoke about the future of primary care and his vision of how virtual care will replace the traditional primary care doctor in the United States leading to better outcomes, improved efficiencies, and lower costs.
Episode Resources * Connect with Arundhati Parmar * aparmar@medcitynews.com * https://twitter.com/aparmarbb * https://medcitynews.com/ * Connect with Andy Ellner * andy@firefly.health * https://www.firefly.health/
This podcast hosted by the editorial team at MedCity News will highlight the strategies, the companies and the personalities spearheading this monumental transformation.